Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

PepGen

Tracked across 3 events · 29 articles · First seen Jun 11, 2025 · Last active May 25, 2026

Sentiment
-40
Attention
2
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
2 -70
Regulatory
Impact: PepGen is being sued for allegedly issuing materially false and/or misleading statements regarding its lead product candidate, PGN-EDO51, and its CONNECT2 study, which could lead to financial losses for the company and its shareholders.
Jun 12, 2025 · 6 articles
2 -50
Business
Impact: PepGen is facing a class action lawsuit due to alleged false statements regarding the effectiveness and safety of its lead product candidate, PGN-EDO51, and the CONNECT2 study.
Jun 11, 2025 · 17 articles
2 0
Business
AstronauTx, a biotechnology company focused on treating Alzheimer's Disease and other neurological disorders, announced the appointments of Dr. Michelle Mellion as Chief Medical Officer (CMO) and Deb Gouveia as Vice President, Clinical Operations and Development…
Impact: Dr. Michelle Mellion previously held a Chief Medical Officer role at PepGen, leading clinical development efforts.
May 12, 2026 · 6 articles
NEWSDESK
Track PepGen live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.